Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jia, PM; Chen, GQ; Huang, XJ; Cai, X; Yang, J; Wang, L; Zhou, YH; Shen, YL; Zhou, L; Yu, Y
   Arsenic trioxide induces multiple myeloma cell apoptosis via disruption ofmitochondrial transmembrane potentials and activation of caspase-3
   CHINESE MEDICAL JOURNAL
   
   P.M. Jia et al., "Arsenic trioxide induces multiple myeloma cell apoptosis via disruption ofmitochondrial transmembrane potentials and activation of caspase-3", CHIN MED J, 114(1), 2001, pp. 19-24
2. Cai, X; Shen, YL; Zhu, Q; Jia, PM; Yu, Y; Zhou, L; Huang, Y; Zhang, JW; Xiong, SM; Chen, SJ; Wang, ZY; Chen, Z; Chen, GQ
   Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
   LEUKEMIA
   
   X. Cai et al., "Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia", LEUKEMIA, 14(2), 2000, pp. 262-270
3. Zhu, XH; Shen, YL; Jing, YK; Cai, X; Jia, PM; Huang, Y; Tang, W; Shi, GY; Sun, YP; Dai, J; Wang, ZY; Chen, SJ; Zhang, TD; Waxman, S; Chen, Z; Chen, GQ
   Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
   JOURNAL OF THE NATIONAL CANCER INSTITUTE
   
   X.H. Zhu et al., "Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations", J NAT CANC, 91(9), 1999, pp. 772-778
4. CHEN GQ; SHI XG; TANG W; XIONG SM; ZHU J; CAI X; HAN ZG; NI JH; SHI GY; JIA PM; LIU MM; HE KL; NIU C; MA J; ZHANG P; ZHANG TD; PAUL P; NAOE T; KITAMURA K; MILLER W; WAXMAN S; WANG ZY; DETHE H; CHEN SJ; CHEN Z
   USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS
   Blood
   
   G.Q. Chen et al., "USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS", Blood, 89(9), 1997, pp. 3345-3353